Percutaneous Local Ablative Therapy for Hepatocellular Carcinoma: A Review and Look into the Future

Annals of Surgery

Volumn 237, Issue 2, 2003, Pages 171-179

  Lau, W Y ^a   Leung, Thomas W T ^a   Yu, Simon C H ^a   Ho, Stephen K W ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ADRENALIN; ALCOHOL; ANTIINFECTIVE AGENT; CARBOPLATIN; CISPLATIN; COLLAGEN; CYTOTOXIC AGENT; RADIOISOTOPE; SODIUM CHLORIDE; WATER; YTTRIUM 90; ANTINEOPLASTIC AGENT; MICROSPHERE; YTTRIUM;

CANCER CONTROL; CANCER LOCALIZATION; CANCER SURGERY; CANCER SURVIVAL; CATHETER ABLATION; CLINICAL RESEARCH; CRYOTHERAPY; DISEASE COURSE; HUMAN; HYPERTHERMIC THERAPY; INTERMETHOD COMPARISON; LASER COAGULATION; LIVER CELL CARCINOMA; MICROWAVE THERAPY; PERCUTANEOUS LOCAL ABLATIVE THERAPY; PRIORITY JOURNAL; RADIOFREQUENCY; REVIEW; SURVIVAL; TECHNOLOGY; TREATMENT INDICATION; TREATMENT OUTCOME; COMPARATIVE STUDY; CRYOSURGERY; DRUG CONTRAINDICATION; INTRALESIONAL DRUG ADMINISTRATION; LIVER RESECTION; LIVER TUMOR; METHODOLOGY; MICROWAVE RADIATION;

ACETIC ACID; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CRYOSURGERY; ETHANOL; HEPATECTOMY; HUMANS; INJECTIONS, INTRALESIONAL; LASER COAGULATION; LIVER NEOPLASMS; MICROSPHERES; MICROWAVES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YTTRIUM RADIOISOTOPES;

EID: 0037317747     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200302000-00005     Document Type: Review

References (84)

1. Bosch FX. Global epidemiology of hepatocellular carcinoma. In: Okuda K, Tabor E, ed. Liver cancer. New York: Churchill Livingstone 1997:13-28.
2. Taylor-Robinson SD, Foster GR, Arora S, et al. Increase in primary liver cancer in the UK, 1979-94. Lancet 1997; 350:1142-1143.
3. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340:745-750.
4. Liver Cancer Study Group of Japan. Primary liver cancers in Japan. Cancer 1980; 45:2663-2669.
5. Lai EC, Fan ST, Lo CM, et al. Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg 1995; 221:291-298.
6. Shiina S, Tagawa K, Niwa Y, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. Am J Roentgenol 1993; 60:1023-1028.
7. Isobe H, Sakai H, Imari Y, et al. Intratumor ethanol injection therapy for solitary minute hepatocellular carcinoma. A study of 37 patients. J Clin Gastroenterol 1994; 18:122-126.
8. Castells A, Bruix J, Bru C, et al. Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology 1993; 18: 1121-1126.
9. Livraghi T, Bolondi L, Lazzaroni S, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients. Cancer 1992; 69:925-929.
10. Lencioni R, Pinto F, Armillotta N, et al. Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: a European experience. Eur Radiol 1997; 7:514-519.
11. Sarin SK, Sreenivas DV, Saraya A, et al. Improved survival with percutaneous ethanol injection in patients with large hepatocellular carcinoma. Eur J Gastroenterol Hepatol 1994; 6:999-1003.
12. Bartolozzi C, Lencioni R, Caramella D, et al. Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization. Radiology 1995; 197:812-818.
13. Mathurin P, Rixe O, Carbonell N, et al. Review article: Overview of medical treatments in unresectable hepatocellular carcinoma - an impossible meta-analysis? Aliment Pharmacol Ther 1998; 12:111-126.
14. Livraghi T, Giorgio A, Marin G, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995; 197:101-108.
15. Brown KT, Brody LA. Percutaneous methods for ablation of hepatic neoplasms. In Blumgart LH, Fong Y, eds. Surgery of the liver and biliary tract. London: WB Saunders Co., 2000:1565-1576.
16. Ohnishi K, Ohyama N, Ito S, et al. Small hepatocellular carcinoma: treatment with US-guided intratumoral injection of acetic acid. Radiology 1994; 193:747-752.
17. Ohnishi K, Yoshioka H, Ito S, et al. Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatology 1998; 27:67-72.
18. Tian JH, Xu BX, Zhang JM, et al. Ultrasound-guided internal radiotherapy using yttrium-90-glass microspheres for liver malignancies. J Nucl Med 1996; 37:958-963.
19. Ho S, Lau WY, Leung WT. Comments on ultrasound-guided internal radiotherapy using yttrium-90 glass microspheres for liver malignancies. J Nucl Med 1997; 38:1169-1170.
20. Giovannale B. Heat shock proteins. In Bicher HI, ed. Consensus on hyperthermia for the 1990s. Clinical Practice in Cancer Treatment. New York: Plenum Press, 1990:95-98.
21. Stone HB, Dewey WC. Biologic basis and clinical potential of local-regional hyperthermia. In Philips TL, ed. Radiation oncology. New York: Raven Press, 1987:2:1-2.
22. Koutcher JA, Barnett D, Kornblith AB, et al. Relationship of changes in pH and energy status to hypoxic cell fraction and hyperthermia sensitivity. Int J Radiat Oncol Biol Phys 1990; 18:1429-1435.
23. Song CW, Kang MS, Rhee JG, et al. The effects of hyperthermia on vascular function, pH and cell survival. Radiology 1980; 137:795-803.
24. Honda N, Guo Q, Uchida H, et al. Percutaneous hot saline injection therapy for hepatic tumors-an alternative to percutaneous ethanol injection therapy. Radiology 1994; 190:53-57.
25. Yoon HK, Song HY, Sung KB, et al. Percutaneous hot saline injection therapy: effectiveness in large hepatocellular carcinoma. J Vasc Interv Radiol 1999; 10:477-482.
26. Huang JF, Kuang M, Lu MD, et al. Percutaneous hyperthermal distilled water injection therapy (PHDT) for liver cancer. Asian J Surg 1999; 22:337-341.
27. Oleson JR, Calderwood SK, Coughlin CT, et al. Biological and clinical aspects of hyperthermia in cancer therapy. Am J Clin Oncol 1988; 11:368-380.
28. Jacquet P, Stephens AD, Averbach AM, et al. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer 1996; 77:2622-2629.
29. Jacquet P, Averbach A, Stephens AD, et al. Heated intraoperative intraperitoneal mitomycin C and early postoperative intraperitoneal 5-fluorouracil: pharmacokinetic studies. Oncology 1998; 55:130-138.
30. Paiva MB, Saxton RE, VanderWerf QM, et al. Cisplatinum and interstitial laser therapy for advanced head and neck cancer: a preclinical study. Lasers Surg Med 1997; 21:423-431.
31. Lu MD, Yin XY, Shen Q, et al. Intra-tumoral injection of boiling carboplatin (BCBP) solution for treatment of liver cancer in animal model. Hepato-Gastroenterology 2001; 48:1328-1332.
32. Hettinga JV, Lemstra W, De Vries EG, et al. Sensitization to cisplatin action by step-down heating in cDDP-sensitive and -resistant cells. Int J Cancer 1995; 61:722-726.
33. Harbord M, Bown S, Mishra L, et al. Phase III trials of intratumoral cisplatin/epinephrine injectable gel for treatment of advanced solid tumors. Proc Am Soc Clin Oncol 1999; abstract 738.
34. Leung TWT, Johnson PJ, Vogl TJ, et al. Percutaneous loco-regional therapy of unresectable hepatocellular carcinoma (HCC) with cisplatin/epinephrine (CDDP/EPI) injectable gel. Proc ECCO 11 2001; abstract 87.
35. Yu SCH, Leung TWT, Lau WY. et al. Direct injection of cisplatin/ epinephrine injectable gel for the treatment of hepatocellular carcinoma [abstract]. HPB 2000; 2:273.
36. Mok TSK, Kanekal S, Lin XR, et al. Pharmacokinetic study of intralesional cisplatin for the treatment of hepatocellular carcinoma. Cancer 2001; 91:2369-2377.
37. Rossi S, Fornari F, Buscarini L. Percutaneous ultrasound-guided radio-frequency electrocautery for the treatment of small hepatocellular carcinoma. J Interv Radiol 1993; 8:97-103.
38. Livraghi T, Goldberg SN, Lazzaroni S, et al. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999; 210:655-661.
39. Ikeda M, Okada S, Ueno H, et al. Radiofrequency ablation and percutaneous ethanol injection in patients with small hepatocellular carcinoma: a comparative study. Jpn J Clin Oncol 2001; 31:322-326.
40. Curley SA, Izzo F, Ellis LM, et al. Radio-frequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surgery 2000; 232:381-391.
41. Lencioni RA, Cioni D, Donati F, et al. Percutaneous treatment of small hepatocellular carcinoma in cirrhosis: radio-frequency thermal ablation vs ethanol injection-a prospective, randomized trial (final report). Radiology 1999; 213(suppl):123.
42. Shiina S, Teratani T, Obi S, et al. Prospective randomized controlled trial comparing percutaneous radio-frequency ablation and percutaneous ethanol injection therapy for small hepatocellular carcinoma. Gastroenterology 2000; 118(suppl):959.
43. Olschewski M, Lencioni R, Allgaier H, et al. A randomized comparison of radio-frequency thermal ablation and percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Pro Am Soc Clin Oncol 2001; abstract 500.
44. Livraghi T, Goldberg SN, Monti F, et al. Saline enhanced radiofrequency tissue ablation in the treatment of liver metastases. Radiology 1997; 202:205-210.
45. Solbiati L, Goldberg SN, Ierace T, et al. Hepatic metastases: Percutaneous radio-frequency ablation with cooled-tip electrodes. Radiology 1997; 205:367-373.
46. Rossi S, Buscarini E, Garbagnati F, et al. Percutaneous treatment of small hepatic tumors by expandable RF needle electrode. Am J Roentgenol 1998; 170:1015-1021.
47. Llovet JM, Vilana R, Bru C, et al. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001; 33:1124-1129.
48. Kato T, Reddy KR. Radiofrequency ablation for hepatocellular carcinoma: help or hazard? Hepatology 2001; 33:1336-1337.
49. Bolondi L, Gaiani S, Celli N, et al. Tumor dissemination after radio-frequency ablation of hepatocellular carcinoma. Hepatology 2001; 34:608.
50. Dong BW, Liang P, Yu XL, et al. Sonographically guided microwave coagulation treatment of liver cancer: an experimental and clinical study. Am J Roentgenol 1998; 171:449-454.
51. Tabuse K, Katsumi M, Kobayashi Y, et al. Microwave surgery: hepatectomy using a microwave tissue coagulator. World J Surg 1985; 9:136-143.
52. Lau WY, Arnold M, Guo SK, et al. Microwave tissue coagulator in liver resection for cirrhotic patients. Aust NZ J Surg 1992; 62:576-581.
53. Hamazoe R, Hirooka Y, Ohtani S, et al. Intraoperative microwave tissue coagulation as treatment for patients with non-resectable hepatocellular carcinoma. Cancer 1995; 75:794-800.
54. Abe T, Shinzawa H, Wakabayashi H, et al. Value of laparoscopic microwave coagulation therapy for hepatocellular carcinoma in relation to tumor size and location. Endoscopy 2000; 32:598-603.
55. Seki T, Wakabayashi M, Nakagawa T, et al. Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer 1994; 74:817-825.
56. Seki T, Wakabayashi M, Nakagawa T, et al. Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy. Cancer 1999; 85:1694-1702.
57. Sato M, Watanabe Y, Kashu Y, et al. Sequential percutaneous microwave coagulation therapy for liver tumors. Am J Surg 1998; 175:322-324.
58. Lu MD, Chen JW, Xie XY, et al. Hepatocellular carcinoma: US-guided percutaneous microwave coagulation therapy. Radiology 2001; 221:167-172.
59. Watanabe Y, Sato M, Abe Y. Laparoscopic microwave coagulonecrotic therapy for hepatocellular carcinoma: a feasibility study of an alternative option for poor-risk patients. J Laparoendosc Surg 1995; 5:169-175.
60. Yamanaka N, Okamoto E, Tanaka T, et al. Laparoscopic microwave coagulonecrotic therapy for hepatocellular carcinoma. Surg Laparosc Endosc 1995; 5:444-449.
61. Saitsu H, Nakayama T, Isomura T, et al. New endoscopic surgical treatment: thoracoscopic microwave coagulo-necrotic therapy for small hepatocellular carcinoma. J Microwave Surg 1994; 12:1-8.
62. Asahara T, Katayama K, Itamoto T, et al. Thoracoscopic microwave coagulation therapy for hepatocellular carcinoma. Hiroshima J Med Sci 1998; 47:125-131.
63. Svaasand LO, Boerslid T, Oeveraasen M. Thermal and optical properties of living tissues: application to laser-induced hyperthermia. Lasers Surg Med 1985; 5:589-602.
64. Steger AC, Lees WR, Walmsley K, et al. Interstitial laser hyperthermia: a new approach to local destruction of tumors. Br Med J 1989; 299: 362-365.
65. Amin Z, Donald JJ, Masters A, et al. Hepatic metastases: interstitial laser photocoagulation with real-time US monitoring and dynamic CT evaluation of treatment. Radiology 1993; 187:339-347.
66. Amin Z, Bown SG, Lees WR. Local treatment of colorectal liver metastases: a comparison of interstitial laser photocoagulation (ILP) and percutaneous alcohol injection (PAI). Clin Radiol 1993; 48:166-171.
67. Nolsoe CP, Torp-Pedersen S, Burcharth F, et al. Interstitial hyperthermia of colorectal liver metastases with a US-guided Nd-YAG laser with a diffuser tip: A pilot clinical study. Radiology 1993; 187:333-337.
68. Gewiese B, Beuthan J. Fobbe F, et al. Magnetic resonance imaging-controlled laser-induced interstitial thermotherapy. Invest Radiol 1994; 29:345-351.
69. Vogl TJ, Muller PK, Hammerstingl R, et al. Malignant liver tumors treated with MR imaging-guided laser-induced thermotherapy: Technique and prospective results. Radiology 1995; 196:257-265.
70. Rubinsky B, Lee CY, Bastacky J, et al. The process of freezing and the mechanism of damage during hepatic cryosurgery. Cryobiology 1990; 27:85-97.
71. Ravikumar TS, Kaleya RN. Cyrotherapy for liver tumors. In Blumgart LH, Fong Y, eds. Surgery of the liver and biliary tract. London: WB Saunders, 2000:1576-1606.
72. Adam R, Majno P, Castaing D, et al. Treatment of irresectable liver tumors by percutaneous cryosurgery. Br J Surg 1998; 85:1493-1494.
73. Izumi N, Asahina Y, Noguchi O. et al. Risk factors for distant recurrence of hepatocellular carcinoma in the liver after complete coagulation by microwave or radiofrequency ablation. Cancer 2001; 91:949-956.
74. Yamamoto J, Okada S, Shimada K, et al. Treatment strategy for small hepatocellular carcinoma: comparison of long-term results after percutaneous ethanol injection therapy and surgical resection. Hepatology 2001; 34:707-713.
75. Arii S, Yamaoka Y, Futagawa S, et al. Results of surgical and non-surgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 2000; 32:1224-1229.
76. Makuuchi M, Hasegawa H, Yamazaki S, et al. The use of operative ultrasound as an aid to liver resection in patients with hepatocellular carcinoma. World J Surg 1987; 11:615-621.
77. Makuuchi M, Hasegawa H, Yamazaki S. Ultrasonically guided sub-segmentectomy. Surg Gynecol Obstet 1985; 161:346-350.
78. Bismuth H, Castaing D, Garden OJ. The use of operative ultrasound in surgery of primary liver tumors. World J Surg 1987; 11:610-614.
79. Lau WY, Leung WT, Ho SKW, et al. Adjuvant intra-arterial lipiodol-iodine-131 for resectable hepatocellular carcinoma: a prospective randomised trial. Lancet 1999; 353:797-801.
80. Vauthey JN, Klimstra D, Franceschi D, et al. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg 1995; 169:28-34.
81. Fuster J, Garcia-Valdecasas JC, Grande L, et al. Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European series. Ann Surg 1996; 223:297-302.
82. Fong Y, Sun RL, Jarnagin W, et al. An analysis of 412 cases of hepatocellular carcinoma at a Western Center. Ann Surg 1999; 229:790-799.
83. Poon RT, Fan ST, Lo CM, et al. Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis. J Clin Oncol 2000; 18:1094-1101.
84. Zhou XD, Tang ZY, Yang BH, et al. Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma. Cancer 2001; 91:1479-1486.